A Startup Has Unlocked a Way to Make Cheap Insulin
Houston-based rBIO has invented a new process to churn out insulin at higher yields using custom-made bacteria.
Houston startup completes testing, prepares biosimilar insulin drug for clinical trials
Houston biotech startup is one step closer to releasing its marquee drug for the global insulin market, which is projected
rBIO Completes Analytical Characterizations of R-biolin, Readies Biosimilar Insulin Drug for Clinical Trial
rBIO's lead biologic drug, R-biolin, aims to disrupt the $90bn insulin market through a biosimilar manufacturing technique that can be massively scaled
Houston A Growing Hub for Biotech
The industrial biotechnology industry is one of the most promising new approaches to pollution prevention, resource conservation and cost reduction.
California-founded biotech startup relocates to join Houston’s emerging bioeconomy
San Diego-based rBIO moved to Houston to take advantage of the growing ecosystem of biomanufacturing and synthetic biology. Photo via
rBIO Succeeds in Biomanufacturing Insulin
For many Type-1 diabetes patients and the health plans that cover them, the cost of insulin is a burdensome problem.